MELVILLE, N.Y.--(BUSINESS WIRE)--Nov. 10, 2005--OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) provided an update today on the status of its pending acquisition of Eyetech Pharmaceuticals, Inc. (Nasdaq:EYET). Eyetech held its special meeting of stockholders today to consider adoption of the merger agreement with OSI. At that meeting, the majority of Eyetech’s outstanding shares of common stock were voted in favor of adoption of the merger agreement.
